CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX)

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COMMON STOCK
Shares outstanding
123,180,519
Total 13F shares
27,360,884
Share change
+2,865,865
Total reported value
$81,277,000
Put/Call ratio
0%
Price per share
$2.97
Number of holders
49
Value change
+$8,330,747
Number of buys
22
Number of sells
22

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2014

As of 31 Dec 2014, CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,360,884 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, Broadfin Capital, LLC, VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, SPHERA FUNDS MANAGEMENT LTD., Opaleye Management Inc., Catalyst Capital Advisors LLC, and Private Capital Advisors, Inc.. This page lists 49 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.